Condition: Liver Diseases · Sponsor: Duke University
The purpose of this study is to identify individuals who have suffered a liver injury arising as an idiosyncratic reaction to a prescription drug or a complementary and alternative medicine. Recently added acute cases enrollment that meets criteria to the protocol. Also added Fibroscans to the protocol that will be completed at baseline and follow-up on chronic subjects.
This description comes directly from the study's public registry record.
Eilene Pham · 9196607253 · eilene.pham@duke.edu
Matt Baum · 919-668-0486 · matt.baum@duke.edu
Always discuss trial participation with your own doctor first.
| University of Southern California | Los Angeles, California, United States | Recruiting |
| Indiana University | Indianapolis, Indiana, United States | Recruiting |
| NIH Clinical Site | Bethesda, Maryland, United States | Recruiting |
| University of Michigan | Ann Arbor, Michigan, United States | Recruiting |
| Univeristy of North Carolina at Chapel Hill | Chapel Hill, North Carolina, United States | Recruiting |
| Thomas Jefferson | Philadelphia, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT00345930